Janssen said Monday it has presented a study supporting the hypothesis that Tremfya, a psoriasis treatment, may differ in pharmacological mechanisms from its competitors because of its ability to bind to CD64+ cells and IL-23.The company presented the study's results, MODIF-Y, during the annual gene
Hanmi Pharmaceutical and KT, one of Korea's top three telecom companies, said that they have jointly invested in digital therapeutics (DTx) developer Digital Pharm, a subsidiary of the Catholic University of Korea's holdings company.In October, Digital Pharm, founded by Professor Kim Dae-jin at Seou
The world’s trade ministers reached an agreement to allow a partial intellectual property (IP) waiver for Covid-19 vaccines at the 12th Ministerial Conference (MC-12) of the World Trade Organization in Geneva, Switzerland, on Friday.Korean Covid-19 vaccine makers are paying keen attention to how the
Korean pharmaceutical companies are racing to develop a lipid nanoparticle (LNP) drug delivery technology, each using a different strategy.Those actively pursuing LNP development are Daewoong Pharmaceutical, Dong-A Socio Holdings, GC Biopharma, and Yuhan Corp.LNP is a drug delivery system key to dev
CG Bio said it has signed contracts to export 5.7 billion won ($4.4 million) worth of Facetem S and AiLEENE, its filler products, to the Middle East and Sweden.The company will export 4.9 billion won worth of its HA fillers to seven Middle East countries, including Syria and the Gulf Cooperation Org
A Ministry of Food and Drug Safety data showed that Takeda Pharmaceutical Korea registered the most patents with the ministry in May.According to the ministry’s drug information website, 14 pharmaceutical companies registered 39 patents last month. Takeda Pharmaceutical Korea registered 10 patents t
LG Chem said Thursday that the U.S. Food and Drug Administration has granted an additional Orphan Drug Designation (ODD) status to its LB54640, which treats genetic obesity due to proopiomelanocortin (POMC) deficiency.In September 2020, the U.S. regulator also designated LB54640 as a rare drug to tr
Hugel said Thursday that it has obtained product approval from Health Canada for its botulinum toxin (BTX) formulation, Letybo, which treats forehead wrinkles.The company had completed an on-site inspection of the Geodu plant, Hugel's botulinum toxin production base, to obtain a Canadian product lic
CG Bio said Thursday that the company signed contracts totaling 5.6 billion won ($4.3 million) with CarePlusOne of Taiwan and OTIMA of Brazil to export its anti-adhesion drug, Mediclore.Anti-adhesion agents prevent the adhesion of tissues or organs. After surgery, medical professionals insert it int
Korea’s major pharmaceutical and biopharmaceutical companies have published reports on their sustainability activities, including corporate social responsibility (CSR) and environment, social, and governance (ESG).On Wednesday, Hanmi Pharmaceutical issued the “2021-22 CSR Report” to explain the comp
Hanall Biopharma said it would exclusively sell Stavaster (ingredient: Rosuvastatin), a hyperlipidemia treatment developed by Sandoz Korea, Novartis' subsidiary for generic and biosimilar business.Hanall Biopharma will exclusively sell and promote Stavaster, and Sandoz Korea will supply it.Korea’s r
Effepharm said it has published the results of Uthever® Nicotinamide Mononucleotide (NMN) research on Frontier in Aging, an authoritative international journal on aging mechanisms.Uthever® NMN, an endogenous compound, has proved safe and improved the NAD+/NADH in the human body, thus realizing the a
A health expert recommended using pneumococcal vaccines, including Pfizer’s, for Covid-19 patients, noting that respiratory infection causes most of the hospitalization of those who developed sequelae even after a full recovery.The World Health Organization defines long Covid as cases that begin wit
Shinpoong Pharmaceutical, already working on multinational phase 3 trials of antimalarial treatment Pyramax in Covid-19 patients, said it would begin a new phase 2 study in Korea.The company said that the new study aims to confirm Pyramax’s effect against the Omicron variant.On Monday, the Ministry
HK inno.N said Tuesday that it has discovered next-generation immune-cancer antibodies in collaboration with Y Biologics. It added that the two companies would use this discovery to expand their research portfolio in antibody treatments and cell therapies such as CAR-T and CAR-NK.Antibodies are prot
Samsung Biologics said it would participate in the world’s largest biopharmaceutical exhibition, "2022 BIO International Convention,” from June 13-16 in San Diego, Calif., organized by the Biotechnology Innovation Organization.BIO holds the annual event in major U.S. cities with bio-clusters, provid
Dongkook Pharmaceutical said Monday it has signed a business agreement with Efil Bioscience to promote their joint research into new drugs.The two companies aim to develop promising new drugs, derive one or more non-clinical candidate substances by the end of this year, and conduct non-clinical rese
Pfizer Korea halted the supply of Vyndaqel Cap. 20 mg (Ingredient: Tafamidis), a transthyretin amyloid polyneuropathy (ATTR-PN) treatment, due to quality issues.The drug, which delays peripheral nerve damage in adult patients with stage 1 symptomatic polyneuropathy, has no substitute drug with the s
Ipsen Korea said it aims to provide a better treatment option for Korean renal cell cancer patients with a Cabometyx and Opdivo combination therapy after receiving approval to use the treatment as first-line therapy."Kidney cancer is a type of cancer difficult to detect at an early stage, and chemot
Dong-A ST said Friday that it has released non-clinical research results on the new drug candidate, DA-1726, in a poster session at the annual American Diabetes Association (ADA) conference.DA-1726 is a new drug under development as an oxyntomodulin analog-based obesity and diabetes treatment, which